Medicare Enrolled
Dr. Kaushik Sen, MD
Medical Oncology · Durham, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sen
Dr. Kaushik Sen is a medical oncology specialist in Durham, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sen performed 824 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sen received a total of $30,279 from 81 pharmaceutical and/or device companies across 1047 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 31% volume in NC
$30,279 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗824
Medicare services
Top 31% in NC for medical oncology
Not available
Unique patients (not deduplicated)
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
459 | $106 | $330 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
288 | $64 | $223 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $92 | $408 |
| New patient office visit, complex (60-74 min) | 27 | $123 | $540 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $58 | $413 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
11 | $75 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$30,279
Total received (2018-2024)
Avg $4,326/year across 7 years
Top 22% in NC for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
1,047
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,161
2023
$3,381
2022
$3,228
2021
$3,148
2020
$1,828
2019
$8,912
2018
$6,621
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$428
PFIZER INC.
$224
Merck Sharp & Dohme LLC
$210
Incyte Corporation
$165
Daiichi Sankyo Inc.
$156
Janssen Biotech, Inc.
$146
ABBVIE INC.
$119
E.R. Squibb & Sons, L.L.C.
$111
Aveo Pharmaceuticals, Inc.
$110
Celgene Corporation
$103
Pharmacosmos Therapeutics Inc.
$91
Eisai Inc.
$89
Bayer Healthcare Pharmaceuticals Inc.
$85
JAZZ PHARMACEUTICALS INC.
$74
Regeneron Healthcare Solutions, Inc.
$71
SOBI, INC
$68
Astellas Pharma US Inc
$66
SHIELD THERAPEUTICS INC
$63
ARRAY BIOPHARMA INC
$60
Takeda Pharmaceuticals U.S.A., Inc.
$59
Genmab U.S., Inc.
$55
AstraZeneca Pharmaceuticals LP
$44
Exelixis Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$40
Alexion Pharmaceuticals, Inc.
$39
Adaptive Biotechnologies Corporation
$37
Karyopharm Therapeutics Inc.
$34
GlaxoSmithKline, LLC.
$34
BeiGene USA, Inc.
$33
GENZYME CORPORATION
$25
Agios Pharmaceuticals, Inc.
$24
Genentech USA, Inc.
$23
ADC Therapeutics America, Inc.
$23
PharmaEssentia USA Corporation
$23
TAIHO ONCOLOGY, INC.
$23
Gilead Sciences, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$21
Lilly USA, LLC
$21
Janssen Pharmaceuticals, Inc
$19
Rigel Pharmaceuticals, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$17
EMD Serono, Inc.
$15
Amgen Inc.
$15
Kyowa Kirin, Inc.
$13
Top 3 companies account for 27.3% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$5,896
Kite Pharma, Inc.
$4,187
Genentech USA, Inc.
$2,581
Novartis Pharmaceuticals Corporation
$1,999
Janssen Biotech, Inc.
$1,471
AstraZeneca Pharmaceuticals LP
$1,003
E.R. Squibb & Sons, L.L.C.
$998
PFIZER INC.
$948
Daiichi Sankyo Inc.
$725
Amgen Inc.
$672
Merck Sharp & Dohme LLC
$657
Merck Sharp & Dohme Corporation
$647
Celgene Corporation
$571
Takeda Pharmaceuticals U.S.A., Inc.
$450
GENZYME CORPORATION
$416
Pharmacyclics LLC, An AbbVie Company
$385
Lilly USA, LLC
$355
Bayer HealthCare Pharmaceuticals Inc.
$339
Eisai Inc.
$325
Gilead Sciences, Inc.
$283
Regeneron Healthcare Solutions, Inc.
$252
GlaxoSmithKline, LLC.
$235
Astellas Pharma US Inc
$225
Bayer Healthcare Pharmaceuticals Inc.
$215
Seagen Inc.
$209
BeiGene USA, Inc.
$205
Rigel Pharmaceuticals, Inc.
$195
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
SANOFI-AVENTIS U.S. LLC
$170
Karyopharm Therapeutics Inc.
$169
ABBVIE INC.
$160
Exelixis Inc.
$149
Alexion Pharmaceuticals, Inc.
$142
Janssen Pharmaceuticals, Inc
$136
ARRAY BIOPHARMA INC
$132
EMD Serono, Inc.
$121
SOBI, INC
$117
EISAI INC.
$115
Dova Pharmaceuticals
$113
PUMA BIOTECHNOLOGY, INC.
$113
Aveo Pharmaceuticals, Inc.
$110
ADC Therapeutics America, Inc.
$108
JAZZ PHARMACEUTICALS INC.
$103
Puma Biotechnology, Inc.
$97
Pharmacosmos Therapeutics Inc.
$91
Sobi, Inc
$87
MorphoSys, US Inc.
$85
Agios Pharmaceuticals, Inc.
$82
Taiho Oncology, Inc.
$80
TerSera Therapeutics LLC
$72
RECORDATI_RARE_DISEASES_INC.
$68
Mylan Institutional Inc.
$66
SHIELD THERAPEUTICS INC
$63
Kyowa Kirin, Inc.
$63
PharmaEssentia USA Corporation
$58
SERVIER PHARMACEUTICALS LLC
$57
Genmab U.S., Inc.
$55
Pharmacyclics LLC, an AbbVie Company
$55
Seattle Genetics, Inc.
$54
Clovis Oncology, Inc.
$52
Adaptive Biotechnologies Corporation
$51
Deciphera Pharmaceuticals Inc.
$48
Acceleron Pharma, Inc.
$42
TAIHO ONCOLOGY, INC.
$42
TESARO, Inc.
$39
TG Therapeutics, Inc.
$25
Heron Therapeutics, Inc.
$24
AbbVie Inc.
$24
Lexicon Pharmaceuticals, Inc.
$23
Spectrum Pharmaceuticals Inc.
$19
Fortovia Therapeutics, Inc.
$18
Jazz Pharmaceuticals Inc.
$17
TG THERAPEUTICS, INC.
$17
Immunomedics, Inc.
$16
Mirati Therapeutics, Inc.
$16
Servier Pharmaceuticals LLC
$15
Verastem, Inc.
$14
Paratek Pharmaceuticals, Inc.
$14
Global Blood Therapeutics, Inc.
$14
AVEO Pharmaceuticals, Inc.
$13
INSYS Therapeutics Inc
$12
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE · ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · EXKIVITY · Enhertu · Erleada · FARESTON · FOTIVDA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · NUZYRA · Nerlynx · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · PADCEV · PANHEMATIN · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · QUZYTTIR · REBLOZYL · RETEVMO · ROLVEDON · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Stivarga · Sustol · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Tivdak · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sen is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sen experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Sen performed 459 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sen receive payments from pharmaceutical companies?
Yes. Dr. Sen received a total of $30,279 from 81 companies across 1,047 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sen's costs compare to other medical oncologists in Durham?
Dr. Sen's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Durham
Browse medical oncologists in Durham ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NC
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NC
Which NC medical oncologists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Kite Pharma, Inc. Payments to Doctors
See all physicians who received payments from Kite Pharma, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology